EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $252 | -57.3% | 12,938 | -35.9% | 0.00% | -77.8% |
Q4 2022 | $590 | -100.0% | 20,199 | -45.6% | 0.01% | -55.0% |
Q2 2022 | $1,649,000 | +138.6% | 37,111 | +124.2% | 0.02% | +100.0% |
Q1 2021 | $691,000 | +98.0% | 16,554 | +120.9% | 0.01% | +233.3% |
Q4 2020 | $349,000 | – | 7,495 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |